VASCERN | European Reference Network's Avatar

VASCERN | European Reference Network

@vascern.bsky.social

Advancing the diagnosis, treatment, and care of patients with rare multisystemic vascular diseases across Europe. πŸ”¬ Evidence-based guidelines | 🌍 Cross-border collaboration | πŸ“š Education πŸ“Œ Visit us: www.vascern.eu

89 Followers  |  53 Following  |  78 Posts  |  Joined: 20.01.2025  |  1.9695

Latest posts by vascern.bsky.social on Bluesky

Post image Post image Post image Post image

VASCERN Days 2025 kicks off in Paris πŸŽ‰

Morning sessions covered coordination, communication, CPMS 2.0, ERASMUS+ training, and new rules and extension.

Now on to the Transversal WG talks on Pregnancy, Registries, and Psychology.

#VASCERNDays2025

09.10.2025 08:41 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Video thumbnail

Big week ahead! Our annual VASCERN Days 2025 kicks off in Paris this Thursday and Friday.

Looking forward to seeing so many of our clinicians, ePAGs, and partners as we keep pushing forward together. 🫢

#VASCERNDays2025 #RareDisease #ERNs #CrossBorderCare

07.10.2025 08:01 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Yesterday we joined FAVA-Multi at Bichat Hospital to share who we are and raise awareness of rare vascular diseases.

Raising awareness is not limited to rare disease day, it happens all year, especially within the healthcare system where patients are treated.

26.09.2025 10:44 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

The VASCERN Summer School 2025 may be over, but the lessons stay with our participants. For Elis, a medical student from Estonia, the highlight was an interactive CADASIL session that offered real clinical insight.

πŸ“’ Applications for the 2026 edition are open until October 27, 2025 πŸ‘‰ bit.ly/42MKOMT

26.09.2025 10:40 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

✨ Last day at the #VASCERN Summer School 2025: no slides, no case discussions β€” just role plays, reflections, and practice in what matters most for patient care: communication.

πŸ“’ Apply now for 2026 πŸ‘‰ vascern.eu/training-and...

20.09.2025 13:38 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

Day 1 of the #VASCERN Summer School 2025 wrapped up

πŸ”Ή HTAD: genetics, diagnosis, treatment, daily life & patient perspectives
πŸ”Ή MSA: Vascular EDS & arterial dissection

Talks, case discussions, coffee breaks and a networking event to come 🌍

#RareDiseases #MedicalEducation

15.09.2025 16:19 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image

πŸ™Œ It begins! #VASCERN Summer School 2025 kicks off today in Paris.

From packing goodies to welcoming a new cohort, the week ahead is all about rare vascular diseases, learning, and connection πŸ’‘

πŸ‘‰ Applications are now open for the 2026 cohort: vascern.eu/training-and...

15.09.2025 08:39 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image

From patient involvement to cross-border collaboration, this is how we make rare care stronger.

πŸ’Ύ Save this for later, πŸ” share it with your network, and explore more at www.vascern.eu

#rarediseases

03.09.2025 14:09 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

VASCERN = Europe’s Reference Network for rare vascular diseases

But what does that actually mean?
Here are 5 facts about who we are, why we exist & how we work.

Swipe through the images ⬇️

03.09.2025 14:09 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image

β˜€οΈWe're pressing pause for the summer. We're taking a short break from social media until September with fresh updates, resources, and news from our network.

Take this time to catch up on our resources at vascern.eu/resources/

Wishing you a restful and healthy #summerbreak!

05.08.2025 08:34 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

Last Friday, our Neurovascular Diseases WG met in Essen πŸ‡©πŸ‡ͺ for a collaborative summer meeting!

Key moments:
βœ… Moyamoya e-learning module validated πŸŽ‰
βœ… Scientific session + hands-on workshop
βœ… Case discussions

Thanks to our hosts & all attendees!

#RareDiseases #CADASIL #Moyamoya #CrossBorderCare

14.07.2025 08:25 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

A full day in Brussels led to big progress.

Our PPL group finalised
βœ”οΈ Clinical Outcome Measures Document (children & adults)
βœ”οΈ Do’s & Don’ts factsheets updated
βœ”οΈ Key issues discussed: compression in infants, surgery, transition, and more

πŸ“ New resources coming soon!
#Lymphoedema #RareDisease

27.06.2025 07:11 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Video thumbnail

Happening today at 17:00 CEST!

Join Prof. Hugues Chabriat for a live webinar on #CADASIL β€” a rare #neurological disease often misdiagnosed. Learn how to spot key clinical signs & improve #diagnosis.

🎯 For #Neurology & stroke HCPs
πŸ‘‰ Register: bit.ly/4dMtprX

23.06.2025 10:50 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
A graphic titled β€œNot Just a Nosebleed” highlights Hereditary Haemorrhagic Telangiectasia (HHT), a rare vascular disease that affects 1 in 5,000 people worldwide. The word β€œnosebleed” features a red blood droplet as the letter β€œO”. On the left, an icon shows 1 in 2 people living with HHT have AVMs in their lungs or liver. On the right, an icon shows 1 in 5 people living with HHT may have gastrointestinal bleeding. The graphic includes the logos of the European Reference Network, VASCERN, and the European Union, along with the date β€œHHT Awareness Day – June 23”.

A graphic titled β€œNot Just a Nosebleed” highlights Hereditary Haemorrhagic Telangiectasia (HHT), a rare vascular disease that affects 1 in 5,000 people worldwide. The word β€œnosebleed” features a red blood droplet as the letter β€œO”. On the left, an icon shows 1 in 2 people living with HHT have AVMs in their lungs or liver. On the right, an icon shows 1 in 5 people living with HHT may have gastrointestinal bleeding. The graphic includes the logos of the European Reference Network, VASCERN, and the European Union, along with the date β€œHHT Awareness Day – June 23”.

Today is World HHT Day 🩸

HHT is a rare disease that affects 1 in 5,000 people. It can cause nosebleeds, internal bleeding, and serious health issues if left undiagnosed.

We’ve created simple, helpful tools to download and share: bit.ly/4liqauL

#WorldHHTDay #RareDisease #SeeBeyond

23.06.2025 08:26 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

🚨 Only 4 days to go! Could that β€œMS” diagnosis actually be #CADASIL?

Join Prof. Chabriat to explore how MRI clues, progression, & family history can support accurate diagnosis.
πŸ—“οΈ 23 June | 17:00 CEST
πŸ”— Register: ec.europa.eu/eusurvey/run...

#Neurology #RareDiseases #Webinar

19.06.2025 12:25 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

🧠 #CADASIL is the most common genetic small vessel disease, first identified 40+ years ago. Still no treatment. Still under-recognised.

Join Prof. Hugues Chabriat for a webinar on its clinical spectrum.
πŸ“… 23 June | πŸ•” 17:00 CEST
Register here: bit.ly/4dMtprX
#CADASIL #RareDiseases #Stroke #Neurology

16.06.2025 12:07 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

πŸ”” Join us on 23 June at 17:00 CEST for the launch of the #Together4RD Toolkit – a key resource to boost ERN-industry collaboration in #RareDisease research.
πŸ”Ή Practical tools
πŸ”Ή Real-world cases
πŸ”Ή Expert speakers
πŸ‘‰ Register: loom.ly/9TZyyX4
#ERDERA

16.06.2025 08:45 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Key Takeaways From The BEE Meeting 2025 On Hereditary Haemorrhagic Telangiectasia | VASCERN Explore the key takeaways from the BEE Meeting 2025 on Hereditary Haemorrhagic Telangiectasia, with expert insights and evidence-based updates.

πŸ—£οΈβ€œEven though a cure doesn’t exist, I believe one day HHT will be a disease to remember not one to fear.”

At the recent Based on Evidence #European meeting, experts came together to share evidence-based ways to improve #HHT care across #Europe.

Read more ➑️ bit.ly/3HmPMbr

04.06.2025 10:47 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

🩸 Our HHT Working Group just wrapped up its Spring Meeting!

Key highlights from the day:
πŸ”Ή Clinical case discussions
πŸ”Ή Do’s & Don’ts for #pregnancy in HHT
πŸ”Ή Registry updates
πŸ”Ή #Ultrasound course in development
πŸ”Ή Preparation for next BEE Meeting

Thank you to all who participated!

22.05.2025 16:36 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

πŸ“’ New resource alert! A gene compendia summarising key genes involved in heritable thoracic aortic diseases like #Marfan & #LoeysDietz syndromes.

For #geneticists, #cardiologists, #researchers & more.
Explore it here ➑️ bit.ly/4kp2YL5

#RareDiseases #Genetics

19.05.2025 12:01 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

πŸ”΄ Today is REDS4VEDS Day 2025, marking 10 years of awareness for vascular Ehlers-Danlos syndrome (vEDS).

Many are still diagnosed only after a medical emergency. We’ve created tools to support vEDS care.

Watch: youtu.be/j6XQJIicJCU?...
More info: bit.ly/4kmcvlV

#REDS4VEDS #vEDS #EDS #RareDisease

16.05.2025 11:52 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

Up to 75% of people with Moyamoya angiopathy suffer from disabling headaches often without proper diagnosis or care.

Our recent webinar on #headache in Moyamoya shares crucial insights on diagnosis & treatment.

πŸŽ₯Watch here: bit.ly/3S0tCOo

#Moyamoya #RareDiseases

12.05.2025 14:10 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

If you are interested in the clinical aspects of lymphatic diseases, don't miss the 30th ISL World Congress of Lymphology. #lymph @vascern.bsky.social
#issva #theralymph

09.05.2025 12:00 β€” πŸ‘ 3    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

Too many HHT patients still face delayed #diagnosis & inconsistent care.

On 23 May in Crema, Italy, the BEE Meeting brings clinicians, researchers & patients together for a full day of evidence-based talks & cross-border #learning.

Register here to join us πŸ‘‰ bit.ly/432kbCV

#RareDiseases

09.05.2025 11:45 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

This is part of our mission to improve rare vascular disease care across Europe.

➑️ Download the tool: bit.ly/3MysT4n

05.05.2025 11:02 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Some rare conditions are difficult to recognise.
Vascular Ehlers-Danlos syndrome (vEDS) is one of them.

We’ve created a structured care pathway to help healthcare professionals:
βœ”οΈ Spot the early signs
βœ”οΈ Confirm the diagnosis
βœ”οΈ Coordinate long-term care

πŸ‘‡

05.05.2025 11:02 β€” πŸ‘ 4    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
Headache in Patients with Moyamoya Angiopathy

Thanks for sharing. Headache is a common symptom in Moyamoya, and there’s still much to learn about how it presents and why.

There's actually a free webinar today exploring this if you’re curious to learn more: bit.ly/43p4FTz

28.04.2025 08:28 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Video thumbnail

⏰ Our webinar on headache in #Moyamoya angiopathy is happening today!

Headache isn’t simple in Moyamoya. It could be an early warning sign or something we don't fully understand yet.

Join us live at 17:00 CEST to learn more. Bring your questions!
πŸ‘‰ bit.ly/43p4FTz

28.04.2025 08:15 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Living with vascular #EhlersDanlos syndrome? Join our webinar to get information on practical tools created by experts & patient representatives.

πŸ—“οΈ 13 May, 17:00 CEST
πŸ‘‰ Register here: bit.ly/3RRmqDV

Live captions in English, French, Spanish, Italian, German, & Dutch available.
#vEDS #RareDiseases

17.04.2025 08:18 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Planning for #pregnancy with a vascular anomaly (VA)? You don’t have to navigate it alone.

Our new patient-friendly booklet covers everything from #contraception to delivery written for people living with a VA such as AVMs, PROS, venous malformations, and more.

πŸ“˜ Download here ➑️ bit.ly/4jDwqwB

15.04.2025 11:16 β€” πŸ‘ 6    πŸ” 5    πŸ’¬ 0    πŸ“Œ 0

@vascern is following 20 prominent accounts